Calcium Potassium Ferrocyanide, a prophylactic mixture comprising this compound and the use thereof for decorporation of Radiocesium in subjects affected by nuclear radiation
First Claim
Patent Images
1. A method comprising:
- administering Calcium Potassium Ferrocyanide CaK2[Fe(CN)6], wherein administering is effective for decorporating radiocesium from an in-vivo system.
1 Assignment
0 Petitions
Accused Products
Abstract
A new prophylactic mixture is prepared for the effective decorporation of *Cs, *Sr, *I from affected subjects in the event of an accidental release of the radioisotopes in the environment due to any nuclear accident. The prophylactic mixture comprising: 1) Calcium Potassium Ferrocyanide [CaK2Fe(CN)6] 2) Calcium Iodate, and 3) Calcium Carbonate, can be formulated in the form of a single tablet, capsule or suspension for easy administration to the radiation affected subjects in cases of emergency or nuclear fallout. Also claimed are the compound calcium potassium ferrocyanide (CaK2Fe(CN)6) and the use thereof for decorporation of *Cs in subjects affected by nuclear radiation.
41 Citations
15 Claims
-
1. A method comprising:
administering Calcium Potassium Ferrocyanide CaK2[Fe(CN)6], wherein administering is effective for decorporating radiocesium from an in-vivo system.
- 2. A prophylactic composition for oral administration for the simultaneous decorporation of radiocesium, radiostrontium and radioiodine from in vivo milieu of subjects affected by the exposure to nuclear radiation, said composition comprising calcium carbonate, calcium iodate and calcium potassium ferrocyanide.
-
15. A method comprising:
administering a composition comprising calcium potassium ferrocyanide ([CaK2Fe(CN)6]), calcium iodate and calcium carbonate for the simultaneous decorporation of radiocesium, radiostrontium and radioiodine from in vivo milieu of subjects affected by the exposure to nuclear radiation.
Specification